DexCom Inc.

NASDAQ: DXCM · Real-Time Price · USD
80.94
0.98 (1.23%)
At close: Aug 15, 2025, 3:59 PM
80.80
-0.17%
After-hours: Aug 15, 2025, 07:51 PM EDT

DexCom Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
606.1M 566.3M 642.3M 1.05B
Short-Term Investments
1.97B 2.16B 1.81B 1.68B
Long-Term Investments
119.3M 38.5M 19M 4.5M
Other Long-Term Assets
53.7M 36.5M 28.1M -4.5M
Receivables
1.03B 987.5M 752.2M 516.6M
Inventory
542.6M 559.6M 306.7M 357.3M
Other Current Assets
58.3M 64.5M 37M 27.4M
Total Current Assets
4.3B 4.43B 3.67B 3.68B
Property-Plant & Equipment
1.4B 1.18B 1.14B 889.9M
Goodwill & Intangibles
126.2M 159.7M 199M 68.5M
Total Long-Term Assets
2.18B 1.84B 1.72B 1.18B
Total Assets
6.48B 6.26B 5.39B 4.86B
Account Payables
345.3M 276.4M 237.9M 189.4M
Deferred Revenue
8M 18.4M 10.1M 2.1M
Short-Term Debt
1.2B n/a 772.6M 20.5M
Other Current Liabilities
n/a 1.02B 663.9M 322.5M
Total Current Liabilities
2.93B 1.56B 1.84B 720.8M
Long-Term Debt
1.24B 2.43B 1.2B 1.8B
Other Long-Term Liabilities
89.4M 59.6M 12.1M 191.5M
Total Long-Term Liabilities
1.45B 2.64B 1.42B 1.89B
Total Liabilities
4.38B 4.2B 3.26B 2.61B
Total Debt
2.59B 2.59B 2.09B 1.82B
Common Stock
400K 400K 400K 100K
Retained Earnings
1.6B 1.02B 479.9M -47.4M
Comprehensive Income
-8M -16.7M -11.6M 500K
Shareholders Equity
2.1B 2.07B 2.13B 2.25B
Total Investments
2.09B 2.2B 1.81B 1.68B